161 related articles for article (PubMed ID: 23975745)
1. Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients.
Spoto B; Mattace-Raso F; Sijbrands E; Pizzini P; Cutrupi S; D'Arrigo G; Tripepi G; Zoccali C; Mallamaci F
Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv181-7. PubMed ID: 23975745
[TBL] [Abstract][Full Text] [Related]
2. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein.
Owens CD; Kim JM; Hevelone ND; Hamdan A; Raffetto JD; Creager MA; Conte MS
J Vasc Surg; 2010 May; 51(5):1152-9. PubMed ID: 20223619
[TBL] [Abstract][Full Text] [Related]
3. Serum leptin, resistin, and lipid levels in patients with end stage renal failure with regard to dialysis modality.
Taskapan MC; Taskapan H; Sahin I; Keskin L; Atmaca H; Ozyalin F
Ren Fail; 2007; 29(2):147-54. PubMed ID: 17365928
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E; Waked E; Nabil M; El-Bendary O
Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
[TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease.
Díez JJ; Iglesias P; Fernández-Reyes MJ; Aguilera A; Bajo MA; Alvarez-Fidalgo P; Codoceo R; Selgas R
Clin Endocrinol (Oxf); 2005 Feb; 62(2):242-9. PubMed ID: 15670203
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.
Zoccali C; Mallamaci F; Tripepi G; Benedetto FA; Cutrupi S; Parlongo S; Malatino LS; Bonanno G; Seminara G; Rapisarda F; Fatuzzo P; Buemi M; Nicocia G; Tanaka S; Ouchi N; Kihara S; Funahashi T; Matsuzawa Y
J Am Soc Nephrol; 2002 Jan; 13(1):134-141. PubMed ID: 11752030
[TBL] [Abstract][Full Text] [Related]
7. Low circulating adiponectin levels are associated with insulin resistance in non-obese peritoneal dialysis patients.
Yoo DE; Lee MJ; Oh HJ; Kim SJ; Shin DH; Yoo TH; Kang SW; Choi KH; Han DS; Han SH
Endocr J; 2012; 59(8):685-95. PubMed ID: 22673293
[TBL] [Abstract][Full Text] [Related]
8. Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report.
Cantarini L; Brucato A; Simonini G; Imazio M; Cumetti D; Cimaz R; Bacarelli MR; Muscari I; Vitale A; Lucherini OM; Galeazzi M; Fioravanti A
Clin Exp Rheumatol; 2013; 31(2):207-12. PubMed ID: 23137677
[TBL] [Abstract][Full Text] [Related]
9. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
10. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients.
Ohashi N; Kato A; Misaki T; Sakakima M; Fujigaki Y; Yamamoto T; Hishida A
Intern Med; 2008; 47(6):485-91. PubMed ID: 18344634
[TBL] [Abstract][Full Text] [Related]
11. Plasma adiponectin levels and clinical outcomes among haemodialysis patients.
Rao M; Li L; Tighiouart H; Jaber BL; Pereira BJ; Balakrishnan VS;
Nephrol Dial Transplant; 2008 Aug; 23(8):2619-28. PubMed ID: 18334528
[TBL] [Abstract][Full Text] [Related]
12. Body fat, insulin resistance, energy expenditure and serum concentrations of leptin, adiponectin and resistin before, during and after pregnancy in healthy Swedish women.
Eriksson B; Löf M; Olausson H; Forsum E
Br J Nutr; 2010 Jan; 103(1):50-7. PubMed ID: 19703326
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin, resistin and leptin response to dietary intervention in diabetic nephropathy.
Kozłowska L; Rydzewski A; Fiderkiewicz B; Wasińska-Krawczyk A; Grzechnik A; Rosołowska-Huszcz D
J Ren Nutr; 2010 Jul; 20(4):255-62. PubMed ID: 20537918
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients.
Zoccali C; Tripepi G; Cambareri F; Catalano F; Finocchiaro P; Cutrupi S; Pizzini P; Testa A; Spoto B; Panuccio V; Enia G; Mallamaci F
J Ren Nutr; 2005 Jan; 15(1):125-30. PubMed ID: 15648021
[TBL] [Abstract][Full Text] [Related]
15. Role of adipose tissue in determining muscle mass in patients with chronic kidney disease.
Castaneda-Sceppa C; Sarnak MJ; Wang X; Greene T; Madero M; Kusek JW; Beck G; Kopple JD; Levey AS; Menon V
J Ren Nutr; 2007 Sep; 17(5):314-22. PubMed ID: 17720100
[TBL] [Abstract][Full Text] [Related]
16. Value of blood adipose tissue hormones concentration--adiponectin, resistin and leptin in the prediction of major adverse cardiac events (MACE) in 1-year follow-up after primary percutaneous coronary intervention in ST-segment elevation acute myocardial infarction.
Piestrzeniewicz K; Luczak K; Goch JH
Neuro Endocrinol Lett; 2008 Aug; 29(4):581-8. PubMed ID: 18766137
[TBL] [Abstract][Full Text] [Related]
17. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients.
Filippidis G; Liakopoulos V; Mertens PR; Kiropoulos T; Stakias N; Verikouki C; Patsidis E; Koukoulis G; Stefanidis I
Blood Purif; 2005; 23(6):421-8. PubMed ID: 16141714
[TBL] [Abstract][Full Text] [Related]
18. [Adipocytokines concentration and metabolic parameters in obese children].
Chrzanowska J; Zubkiewicz-Kucharska A; Noczyńska A
Pediatr Endocrinol Diabetes Metab; 2011; 17(3):145-51. PubMed ID: 22027068
[TBL] [Abstract][Full Text] [Related]
19. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function.
Risch L; Saely C; Hoefle G; Rein P; Langer P; Gouya G; Marte T; Aczel S; Drexel H
Clin Chim Acta; 2007 Feb; 376(1-2):108-13. PubMed ID: 16956602
[TBL] [Abstract][Full Text] [Related]
20. Adipocytokines in primary antiphospholipid syndrome: potential markers of low-grade inflammation, insulin resistance and metabolic syndrome.
Rodrigues CE; Vendramini MB; Bueno C; Bonfá E; de Carvalho JF
Clin Exp Rheumatol; 2012; 30(6):871-8. PubMed ID: 22935544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
